All News

Working in an office may be a greater COPD risk than working in a mine. 

$359 million per year, and nearly 40 cumulative hours per week are spent mitigating shortages.

Unsupported claims of safety and effectiveness have concnerned the FDA. 

Pilot program will include a blockchain-secured distribution.

Now approved to be used in combiantion with lenalidomide and dexamethasone. 

Bevacizumab-bvzr is an mAb endothelial growth factor biosimilar.

Patient data provides a rich resource that can help address the problem of opioid misuse and addiction among their health plan members.

Complement inhibitor is the first treatment for the rare autoimmune disorder.

First treatment approved for the condition with nasal polyps.

Walgreens launched a national effort to help consumers safely dispose of unwanted or expired medications year-round in all of its pharmacies.

Walgreens and several organizations will educate about HIV testing and antiretroviral medications to prevent HIV transmission on National HIV Testing Day on June 27.

Pharmacist intervention keeps pharmacy systems up to date, secure, and running optimally.

It's time for a little civic pride! Did your city make the list?

Medical cannabis is the subject of a new master’s degree program at the University of Maryland School of Pharmacy.

New features to ease injection administration. 

Funds to help establish education and training for pharmacy technicians.

The first drug approved to specifically treat post-partum depression.

Approved to treat pediatric patients ages 6 years and older with cystic fibrosis

Most common errors include incorrect drugs and strength.

An open letter to the California State Board of Pharmacy.

Programs increasingly cater to the uninsured and underinsured

Staying abreast of the pharmacy profession can be easier, with the right tools.

A three-year study finds that aspirin may have a role in preventing COPD flare ups.

Try your hand at new services, activism, and product offerings!

First non-insulin drug for pediatric use approved in nearly 20 years.

Type 2 diabetes mellitus is a risk factor for incident heart failure, according to a new scientific statement from the American Heart Association (AHA), and it increases the risk of morbidity and mortality in patients with established disease.

Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.

Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.